Ozempic, Wegovy not associated with higher risk of suicidal ideation in large review of US health records

Use of the medicine semaglutide for weight loss or type 2 diabetes wasn’t associated with a higher risk of suicidal ideation than other medicines for those conditions in a large new review of US health records that was backed by the National Institutes of Health.

Related Keywords

,Nora Volkow ,Rong Xu ,European Medicines Agency ,National Institute On Drug Abuse ,Pharmacovigilance Risk Assessment Committee ,Drug Administration ,Case Western Reserve University School Of Medicine ,National Institutes Of Health ,National Institutes ,Case Western Reserve University School ,National Institute ,Drug Abuse Director ,Event Reporting System ,